{
    "nctId": "NCT03688958",
    "briefTitle": "Iodine Supplementation on Breast Cancer",
    "officialTitle": "Effect of Dietary Iodine Supplementation on the Proliferation of Breast Cancer",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": "Tumor response [change in size]",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically confirmed, stage II or III breast cancer\n* Scheduled to surgical of the primary tumor (stage II)\n* Will receive neoadjuvant FEC/TE chemotherapy (stage III).\n* age \\> 18 and \\< 81 years\n* Non-pregnant\n* Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1\n\nExclusion Criteria:\n\n* Known sensitivity to iodine or FEC/TE\n* Concurrent severe and/or uncontrolled disease\n* Myocardial infarction within the last six months before the study\n* Unstable or uncontrolled hypertension\n* Thyroid dysfunction",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}